TSS
Two Sigma Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Buy |
+29,512
| New | +$1.62M | 0.2% | 112 |
|
|
2025
Q1 | – | Sell |
-3,284
| Closed | -$216K | – | 1466 |
|
|
2024
Q4 | $216K | Sell |
3,284
-100,143
| -97% | -$6.58M | 0.03% | 762 |
|
|
2024
Q3 | $7.27M | Buy |
103,427
+74,598
| +259% | +$5.24M | 0.12% | 31 |
|
|
2024
Q2 | $2.37M | Sell |
28,829
-8,843
| -23% | -$728K | 0.03% | 162 |
|
|
2024
Q1 | $3.29M | Buy |
37,672
+17,364
| +86% | +$1.52M | 0.03% | 108 |
|
|
2023
Q4 | $1.96M | Buy |
20,308
+12,552
| +162% | +$1.21M | 0.02% | 127 |
|
|
2023
Q3 | $686K | Sell |
7,756
-3,971
| -34% | -$351K | 0.01% | 319 |
|
|
2023
Q2 | $1.02M | Buy |
+11,727
| New | +$1.02M | 0.02% | 180 |
|
|
2022
Q3 | – | Sell |
-8,803
| Closed | -$730K | – | 1401 |
|
|
2022
Q2 | $730K | Buy |
+8,803
| New | +$730K | 0.03% | 198 |
|
|
2021
Q3 | – | Sell |
-3,350
| Closed | -$280K | – | 881 |
|
|
2021
Q2 | $280K | Buy |
+3,350
| New | +$280K | 0.01% | 360 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 631 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 703 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 541 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 606 |
|
|
2020
Q1 | – | Sell |
-20,905
| Closed | -$1.77M | – | 686 |
|
|
2019
Q4 | $1.77M | Buy |
+20,905
| New | +$1.77M | 0.01% | 68 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 761 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 914 |
|
|
2019
Q1 | – | Sell |
-4,154
| Closed | -$354K | – | 889 |
|
|
2018
Q4 | $354K | Sell |
4,154
-6,443
| -61% | -$549K | ﹤0.01% | 449 |
|
|
2018
Q3 | $1.03M | Sell |
10,597
-19,968
| -65% | -$1.94M | 0.01% | 174 |
|
|
2018
Q2 | $2.88M | Buy |
30,565
+14,623
| +92% | +$1.38M | 0.01% | 75 |
|
|
2018
Q1 | $1.29M | Buy |
15,942
+12,698
| +391% | +$1.03M | 0.01% | 214 |
|
|
2017
Q4 | $289K | Buy |
+3,244
| New | +$289K | 0.01% | 417 |
|
|
2017
Q3 | – | Sell |
-10,786
| Closed | -$980K | – | 892 |
|
|
2017
Q2 | $980K | Buy |
+10,786
| New | +$980K | 0.19% | 96 |
|